Key result
Warfarin therapy was prescribed to only 56% of eligible patients with ischemic stroke and AF, with lower use in those aged ≥75 years (40%) vs <75 years (80%).
Why the study?
What proportion of acute ischemic stroke patients with atrial fibrillation are prescribed appropriate warfarin therapy?
Population
42 patients admitted to a teaching hospital with a diagnosis of acute ischaemic stroke and atrial…
Design
Cohort
Authors
Loading...
Low warfarin use in eligible elderly AF stroke patients signals a persistent gap; leaves open whether contemporary NOAC uptake has resolved age-related disparities.
Observational (n=42)
No
What proportion of acute ischemic stroke patients with atrial fibrillation are prescribed appropriate warfarin therapy?
The study highlights the under-prescription of warfarin for secondary stroke prophylaxis in eligible AF patients, particularly in the elderly (≥75 years).
Craig et al. (2000) conducted an observational in Ischaemic stroke and atrial fibrillation (n=42). Warfarin therapy was evaluated on Appropriate antithrombotic therapy (warfarin) prescription in eligible patients. Warfarin therapy was prescribed to only 56% of eligible patients with ischemic stroke and AF, with lower use in those aged ≥75 years (40%) vs <75 years (80%).